Recipharm enhances its facility in France with a new manufacturing equipment

Recipharm, the contract development and manufacturing organisation (CDMO), announces its new Blow-fill-seal machinery is now operational following a substantial investment last year at its facility in Kaysersberg, France.

The 18 million investment adds a new Blow-fill-seal high-speed filling and packaging line to the site, taking the total number of lines to eight and increasing the facility’s manufacturing capacity by 200 million unidoses/year. In addition, the investment adds 2,400 square metres to the facility creating space for a further three machines, which will ultimately allow the site to manufacture over 1.2 billion unidoses/year.

The Kaysersberg site, located in Alsace, France, is a facility specialising in Blow-fill-seal technology for sterile liquids. The site manufactures single dose units and has an advanced aseptic process for sterile liquid packaging applications.

SOURCE: recipharm
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.